Serum Institute of India (India)

Recent papers from Serum Institute of India (India)

1. Selective laser melting of LM25 aluminium alloy reinforced with boron carbide and graphite for machine learning based wear prediction and microstructural characterizationScientific Reports · 2026
2. Safety and Preliminary Efficacy of Dengue Monoclonal Antibody in Adult PatientsJAMA Network Open · 2026
3. Supporting 3Rs approaches in biologicals testing: responses from a survey of Manufacturers, Contract Research Organisations, National Control Laboratories and National Regulatory AuthoritiesBiologicals · 2026
4. Persistence of Serum Bactericidal Antibody in the First 2-Years After Immunization with Pentavalent Meningococcal ACWYX Vaccine in Malian Infants and ToddlersClinical Infectious Diseases · 2026
5. Evaluation of Salmonella Paratyphi specific antibody quantity and function after vaccination and controlled human infectionThe Journal of Immunology · 2026
6. Impact of Media and Induction Strategy on Physicochemical Characteristics and Immunogenicity of Recombinant fHbp-PorA Chimeric Protein: A Promising Meningococcal B Vaccine Candidate Produced in Escherichia coliVaccines · 2026
7. Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA ConsortiumInternational Journal of Cancer · 2026
8. Safety and Immunogenicity of SII’s 10-Valent Pneumococcal Conjugate Vaccine (PCV10-SII) in Vietnamese Children Aged from 6 Weeks to 24 Months: An Open-Label, Single-Arm Bridging StudyVaccines · 2026
9. Optimization of Fermentation Conditions Using Design of Experiment (DoE) to Enhance the Production of Antigenic Capsular Polysaccharides From Streptococcus pneumoniae Serotype 18C for Pneumococcal Vaccine DevelopmentBiotechnology and Applied Biochemistry · 2026
10. Growth with Equity and Green Resilience: Strategic Imperatives for the Indian Economy @ 20472026
11. Growth with Equity and Green Resilience: Strategic Imperatives for the Indian Economy @ 20472026
12. Development and validation of immunological assays for preclinical evaluation of a novel bivalent typhoid conjugate vaccineHuman Vaccines & Immunotherapeutics · 2026
13. Phase II multicentre double-blind randomised controlled trial of a Bivalent VaccInation against Salmonella Typhi and Paratyphi A (BiVISTA) using a controlled human infection model of paratyphoid A infection: study protocolBMJ Open · 2026
14. Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulinScientific Reports · 2026
15. What’s new and what’s next for vaccines in 2026?Vaccine Insights · 2026
16. Statistical approach for media optimization of fHbp–PorA chimeric protein expression in Escherichia coli ; development of a promising Meningococcal B vaccineJournal of Industrial Microbiology & Biotechnology · 2026
17. Systematic Development and Validation of a Bradford-Based Protein Quantification Method for Novel Multi-Dose R21 Malaria Vaccine Formulated with 2-Phenoxy Ethanol (2-PE)Vaccines · 2025
18. Nasopharyngeal pneumococcal carriage in Indian children following 10-valent PCV (PNEUMOSIL®) introduction through India's universal immunization program: A post licensure cross-sectional study.Vaccine · 2025
19. Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccinesInternational Journal of Pharmaceutics X · 2025
20. Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyondHuman Vaccines & Immunotherapeutics · 2025